Xilio Therapeutics (XLO) News Today → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free XLO Stock Alerts $1.07 +0.06 (+5.94%) (As of 02:20 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineXilio Therapeutics, Inc. (NASDAQ:XLO) Short Interest Updateamericanbankingnews.com - April 26 at 2:16 AMXilio Therapeutics (NASDAQ:XLO) Shares Up 1%americanbankingnews.com - April 25 at 2:24 AMXilio Therapeutics (XLO) Price Target Increased by 17.86% to 5.61msn.com - April 17 at 6:22 PM3 Biotech Stocks to Invest In Right Now for Long-Term Gainsstocknews.com - April 12 at 1:00 PMGilead Sciences, Inc. Buys 485,250 Shares of Xilio Therapeutics, Inc. (NASDAQ:XLO) Stockinsidertrades.com - April 4 at 6:16 AMXLO Stock Earnings: Xilio Therapeutics Beats EPS for Q4 2023investorplace.com - April 2 at 12:01 AMXilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Resultsglobenewswire.com - April 1 at 4:05 PMXilio Shares Take Flight Premarket After Gilead Dealmarketwatch.com - March 29 at 8:08 AMWhy Is Xilio Therapeutics (XLO) Stock up 168% Today?investorplace.com - March 28 at 11:10 AMXilio Therapeutics Plans Private Placement, Job Cutsmarketwatch.com - March 28 at 10:08 AMXilio Prices Private Placement Of $11.3 Mln Of Shares, Updates XTX202 Trial; To Axe 21% Of Jobsmarkets.businessinsider.com - March 28 at 10:08 AMmarketbeat.com - March 28 at 10:01 AMmarketbeat.com - March 28 at 9:33 AMXilio Therapeutics Announces $11.3 Million Private Placement Equity Financingglobenewswire.com - March 28 at 7:05 AMmarketbeat.com - March 28 at 7:03 AMXilio Therapeutics to Participate in Novel Immuno-Oncology Panel at TD Cowen 44th Annual Health Care Conferenceglobenewswire.com - February 28 at 4:01 PMXilio Therapeutics Inc XLOmorningstar.com - February 27 at 11:45 PMXilio Therapeutics to Present at Guggenheim 6th Annual Biotechnology Conferencefinance.yahoo.com - January 31 at 7:02 PMXilio Therapeutics Highlights Recent Advances Across Clinical Pipeline and Encouraging Preliminary Phase 1 Safety Data for XTX301, a Tumor-Activated IL-12, Further Validating the Promise of Its Tumor-Activated Immuno-Oncology Therapiesfinance.yahoo.com - January 8 at 8:37 AMWerewolf Therapeutics: Still In The Race To Develop Next Generation Cytokinesseekingalpha.com - December 28 at 10:46 PMXilio Therapeutics Announces Initiation of Enrollment for Phase 1 Combination Trial of XTX101, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, and Updated Phase 1 Monotherapy Datafinance.yahoo.com - December 7 at 8:38 AMXilio Therapeutics GAAP EPS of -$0.61msn.com - November 10 at 1:22 PMXilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 9 at 4:36 PMPromising Clinical Trials and Potential Therapies Propel Buy Rating for Xilio Therapeuticsmarkets.businessinsider.com - November 8 at 12:37 AMXilio Announces Initial Monotherapy Safety and Anti-Tumor Activity Data for XTX202, a Tumor-Activated, Engineered, Beta-Gamma IL-2, in Late Line Patients with Advanced Solid Tumorsfinance.yahoo.com - November 3 at 1:34 PMXilio to Host Virtual Investor Conference Call and Webcast on Monday, November 6, 2023 to Review Progress Across Pipeline, Including Phase 1/2 Clinical Data for XTX202, a Tumor-Activated, Engineered, Beta-Gamma IL-2, Presented at the SITC Annual Meetingfinance.yahoo.com - October 31 at 12:03 PMXilio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meetingfinance.yahoo.com - September 27 at 7:00 PMXilio Therapeutics Appoints Katarina Luptakova As CMOmarkets.businessinsider.com - September 5 at 3:11 PMXilio Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conferencefinance.yahoo.com - September 5 at 3:11 PMXilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officerfinance.yahoo.com - September 5 at 3:11 PMQ2 2023 Xilio Therapeutics Inc Earnings Callfinance.yahoo.com - August 18 at 6:16 AMXilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 14 at 7:42 AMXilio Therapeutics Announces Promotion of Chris Frankenfield to Chief Operating Officerfinance.yahoo.com - August 3 at 6:06 PMXLO - Xilio Therapeutics, Inc.uk.finance.yahoo.com - July 20 at 7:39 AMXilio Therapeutics Announces Preliminary Clinical Data from Phase 1 Trial of XTX101, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, in Patients with Advanced Solid Tumorsfinance.yahoo.com - May 25 at 7:34 PMChardan Capital Reiterates Xilio Therapeutics (XLO) Buy Recommendationmsn.com - May 12 at 12:18 AMXilio Therapeutics GAAP EPS of -$0.83 beats by $0.06msn.com - May 10 at 8:15 AMXilio Therapeutics, Inc.: Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2023 Financial Resultsfinanznachrichten.de - May 9 at 12:12 PMXilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2023 Financial Resultsfinance.yahoo.com - May 9 at 12:12 PMXilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)finance.yahoo.com - April 3 at 6:31 PMXilio Therapeutics Announces Pipeline and Business Updates for the Fourth Quarter and Full Year 2022 Financial Resultsfinance.yahoo.com - March 2 at 7:54 PMXilio Therapeutics to Present at Upcoming Investor Conferencesfinance.yahoo.com - February 27 at 7:47 AMXilio Therapeutics to Present at the Citi 2023 Virtual Oncology Leadership Summitfinance.yahoo.com - February 16 at 8:13 AMXilio Therapeutics to Present at the Guggenheim Healthcare Talks Oncology Dayfinance.yahoo.com - February 2 at 9:42 AMXilio Therapeutics, Inc. (NASDAQ:XLO) Sees Significant Decrease in Short Interestmarketbeat.com - January 27 at 1:36 AMInstitutions profited after Xilio Therapeutics, Inc.'s (NASDAQ:XLO) market cap rose US$33m last week butprivate equity firms profited the mostfinance.yahoo.com - January 26 at 8:27 AMXLO Xilio Therapeutics, Inc.seekingalpha.com - January 25 at 2:23 PMThese 2 ‘Strong Buy’ Penny Stocks Are on Track for Massive Gains, Say Analystsfinance.yahoo.com - January 25 at 2:23 PMXilio Therapeutics to Host Live Virtual Program Spotlighting XTX301, a Tumor-Activated IL-12finance.yahoo.com - November 23 at 12:21 PMXilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2022 Financial Resultsfinance.yahoo.com - November 9 at 9:36 AM Get Xilio Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for XLO and its competitors with MarketBeat's FREE daily newsletter. Email Address Move Your Money Before May 22 (Ad)The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. XLO Media Mentions By Week XLO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XLO News Sentiment▼0.220.33▲Average Medical News Sentiment XLO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XLO Articles This Week▼30▲XLO Articles Average Week Get Xilio Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for XLO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AADI News Today NXTC News Today BOLT News Today RMTI News Today OCUP News Today CALC News Today APLM News Today NRXP News Today DARE News Today JAGX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XLO) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xilio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
